REFRACTORY BRAIN NEOPLASM
Clinical trials for REFRACTORY BRAIN NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY BRAIN NEOPLASM trials appear
Sign up with your email to follow new studies for REFRACTORY BRAIN NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets Hard-to-Treat cancers in kids and young adults
Disease control OngoingThis early-phase trial tested a combination of three drugs—dasatinib, temsirolimus, and cyclophosphamide—in 14 children and young adults with advanced solid tumors that had spread, returned, or stopped responding to standard treatments. The main goals were to find the safest dose…
Matched conditions: REFRACTORY BRAIN NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New hope for kids with aggressive brain cancers: early trial tests Immune-Boosting drug
Disease control OngoingThis early-stage trial is testing the safety and early effectiveness of a drug called pembrolizumab in children and young adults whose aggressive brain tumors have come back or stopped responding to standard treatments. The drug is a type of immunotherapy designed to help the bod…
Matched conditions: REFRACTORY BRAIN NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 13, 2026 20:17 UTC